Home » Authors » Nuala Moran

Articles by Nuala Moran

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...